Compare BIO & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | KNX |
|---|---|---|
| Founded | 1952 | 1989 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Trucking Freight/Courier Services |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.7B |
| IPO Year | 1994 | 2010 |
| Metric | BIO | KNX |
|---|---|---|
| Price | $375.28 | $66.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 20 |
| Target Price | ★ $339.75 | $65.00 |
| AVG Volume (30 Days) | 250.5K | ★ 3.0M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ 142.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,583,200,000.00 | ★ $7,469,689,000.00 |
| Revenue This Year | $2.74 | $6.91 |
| Revenue Next Year | $3.20 | $7.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.65 | ★ 0.80 |
| 52 Week Low | $236.73 | $38.63 |
| 52 Week High | $396.23 | $82.86 |
| Indicator | BIO | KNX |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 41.22 |
| Support Level | $284.88 | $58.86 |
| Resistance Level | $396.23 | $67.75 |
| Average True Range (ATR) | 9.71 | 2.30 |
| MACD | -2.69 | -0.19 |
| Stochastic Oscillator | 38.92 | 14.74 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Knight-Swift Transportation is the largest full-truckload carrier in the US, with a diversified transportation offering. Roughly 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 63% and less than truckload 19%. Truck brokerage and other asset-light logistics services make up 8% of revenue, with intermodal near 5%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue is from services offered to shippers and third-party truckers, including equipment maintenance and leasing.